Medications

Hot flash drug shows significant benefits in clinical trials

The investigational drug elinzanetant significantly reduces the frequency and severity of hot flashes associated with menopause while improving women's quality of life, according to new UVA Health research published in the ...

Diseases, Conditions, Syndromes

In COVID-19 patients, neurological symptoms may last up to three years

Scientists from Northwestern Medicine and the School of Medicine at CES University and CES Clinic in Colombia have determined that more than 60% of people who contracted COVID-19 have neurological symptoms that impact their ...

page 3 from 40